Brief Communication: Electromagnetic Fields Improve Visuospatial Performance and Reverse Agraphia in a Parkinsonian Patient

References

• Boller F., Passafiume D., Rogers K., Morrow L., Kim Y. Visuospatial impairment in Parkinson's disease: role of perceptual and motor factors and of disease stage. Neurology 1982; 32: 189
   Web of Science ®Google Scholar
• Boller F., Passafiume D., Keefe N. C., Rogers K., Morrow L., Kim Y. Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Archives of Neurology 1984; 41: 485–490
   PubMed Web of Science ®Google Scholar
• Cash R., Dennis R., L'Heureux R., Raisman R., Javoy-Agid F., Scatton B. Parkinson's disease and dementia: norepinephrine and dopamine in locus ceruleus. Neurology 1987; 37: 42–46
   PubMed Web of Science ®Google Scholar
• Eliasberg W. G. Pen, paper and parkinsonism. Geriatrics 1959; 14: 705–708
   PubMedGoogle Scholar
• Freedman M., Leach L., Kaplan E., Winocur G., Shulman K. I., Delis D. C. Clock drawing: a neuropsychological analysis. Oxford University Press, New York 1994; 6–7
   Google Scholar
• Iversen S. D. Striatal function and stereotyped behavior. Psychobiology of the striatum, A. R. Cools, A. H. M. Lohman, J. H. L. Van den Bercken. North Holland Publishing Co, Amsterdam 1977; 99–118
   Google Scholar
• Javoy-Agid F., Agid Y. Is the mesocortical dopaminergic system involved in Parkinson's disease?. Neurology 1980; 30: 1326–1330
   PubMed Web of Science ®Google Scholar
• Knopp W. Explorations in the assessment and meaning of the subclinical extrapyramidal effect of neuroleptic drugs. Pharmakopsychiatrie 1968; 1: 54–61
   Google Scholar
• Lebrun Y., Hoops R. Intelligence and aphasia. Swets & Zeitlinger, B. V, Amsterdam 1974
   Google Scholar
• Lees A. J., Smith E. Cognitive deficits in the early stages of Parkinson's disease. Brain 1983; 106: 257–270
   PubMed Web of Science ®Google Scholar
• Levin B. E., Llabre M. M., Reisman S., Weiner W. J., Sanchez-Ramos J., Singer C., Brown M. C. Visuospatial impairment in Parkinson's disease. Neurology 1991; 41: 365–369
   PubMed Web of Science ®Google Scholar
• LeWitt P. Micrographia as a focal sign of neurological disease. Journal of Neurology. Neurosurgery and Psychiatry 1983; 46: 1152–1153
   PubMed Web of Science ®Google Scholar
• Lezak M. D. Neuropsychological assessmentThird Edition. Oxford University Press, New York 1995; 584–585
   Google Scholar
• Ljungberg T., Ungerstedt U. Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain. Experimental Neurology 1976; 53: 585–600
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stern Y., Rosen J., Leventhal J. Depression, intellectual impairment and Parkinson's disease. Neurology 1981; 31: 645–650
   PubMed Web of Science ®Google Scholar
• McFie J., Zangwill O. L. Visual constructive disabilities associated with lesion of the left cerebral hemisphere. Brain 1960; 83: 243–260
   Web of Science ®Google Scholar
• Messerli P., Seron X., Tissot R. Quelques aspects des troubles de la programmation dans le syndrome frontal. Archives Suisse de Neurologie, Neurochirurgie et de Psychiatric 1979; 125: 23–35
   PubMedGoogle Scholar
• Mohr E., Juncos J., Cox C., Litvan I., Fedio P., Chase T. N. Selective deficits in cognition and memory in high-functioning Parkinsonian patients. Journal of Neurology, Neurosurgery and Psychiatry 1990; 53: 603–606
   PubMed Web of Science ®Google Scholar
• Mortimer J. A., Pirozzolo F. J., Hansch E. C., Webster D. D. Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology 1982; 32: 133–137
   PubMed Web of Science ®Google Scholar
• Nutt J. G., Hammerstand J. P., Gancher S. T. Parkinson's disease-100 maxims. Edward Arnold, London 1992; 12–13
   Google Scholar
• Parkinson J. An essay on the shaking palsy. Sherwood, Neeley and Jones, London 1987
   Google Scholar
• Pillon B., Dubois B., Bonnet A. M., Esteguy M., Guimaraes J., Vigouret J. M., L'hermitte F., Agid Y. Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology 1989; 39: 762–768
   PubMed Web of Science ®Google Scholar
• Pirozzolo F. J., Hansch E. C., Mortimer J. A. Dementia in Parkinson's disease: A neuropsychological analysis. Brain and Cognition 1982; 1: 71–83
   PubMedGoogle Scholar
• Riklan M., Zahn T. P., Diller L. Human figure drawings before and after chemosurgery of the basal ganglia in Parkinsonism. Journal of Nervous and Mental Disease 1962; 135: 500–506
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease. International Journal of Neuroscience 1992a; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of parkinsonism. International Journal of Neuroscience 1992b; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields in the treatment of Parkinson's disease with the “on-off” phenomenon. International Journal of Neuroscience 1992c; 66: 97–106
   PubMed Web of Science ®Google Scholar
• Sandyk R. The effects of picotesla range magnetic fields on perceptual organization and visual memory in parkinsonism. International Journal of Neuroscience 1993; 73: 207–219
   PubMed Web of Science ®Google Scholar
• Sandyk R. A drug naive Parkinsonian patient successfully treated with electromagnetic fields. International Journal of Neuroscience 1994a; 79: 99–110
   PubMed Web of Science ®Google Scholar
• Sandyk R. Reversal of a visuoconstructional deficit in report of five cases. International Journal of Neuroscience 1994b; 75: 213–228
   PubMed Web of Science ®Google Scholar
• Sandyk R. Improvement in word fluency performance in Parkinson's disease by administration of electromagnetic fields. International Journal of Neuroscience 1994c; 77: 23–46
   PubMedGoogle Scholar
• Sandyk R. Treatment of Parkinson's disease with magnetic fields reduces the requirement for antiparkinsonian medications. International Journal of Neuroscience 1994d; 74: 191–201
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picotesla magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993; 69: 167–183
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Reversal of visual neglect in Parkinson's disease by treatment with picotesla range magnetic fields. International Journal of Neuroscience 1993a; 73: 93–107
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Rapid improvement of visuoperceptive functions by picotesla range magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993b; 70: 233–254
   PubMedGoogle Scholar
• Siegfried J. Die parkinsonsche krankheit und ihre behandlung. Springer Verlag, Wien 1968; 106
   Google Scholar
• Ska B., Nespoulous J. L. Human figure and bicycle drawings by normal aged subjects and Alzheimer's type patients. Journal of Clinical and Expoerimental Neuropsychology 1987; 9: 261
   Web of Science ®Google Scholar
• Ska B., Desilets H., Nespoulous J. L. Performances visuoconstructive et vieillissement. Pychologica Belgica 1986; 27: 25–42
   Google Scholar
• Stern Y., Langston J. W. Intellectual changes in patients with MPTP-induced parkinsonism. Neurology 1985; 35: 1506–1509
   PubMed Web of Science ®Google Scholar
• Stern Y., Mayeux R. Possible dopaminergic basis for perceptual motor dysfunction. Alzheimer's and Parkinson's disease strategies for research and development, A. Fisher, I. Hanin, C. Lachman. Plenum Press, New York 1986; 185–189
   Google Scholar
• Stern Y., Mayeux R., Cote L. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism. Archives of Neurology 1984; 41: 1086–1089
   PubMedGoogle Scholar
• Stem Y., Mayeux R., Rosen J., Ilson J. Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. Journal of Neurology, Neurosurgery and Psychiatry 1983; 46: 145–151
   PubMed Web of Science ®Google Scholar
• Taylor E. M. The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, Mass 1959
   Google Scholar
• Tetrud J. W. Preclinical Parkinson's disease: detection of motor and nonmotor manifestations. Neurology 1991; 41(suppl, 2)69–71
   PubMed Web of Science ®Google Scholar
• Teuber H. L., Proctor F. I. Some effects of basal ganglia lesions in subhuman primates and man. Neuropsychoogia 1964; 2: 83–93
   Web of Science ®Google Scholar
• Villardita C., Smimi P., Le Pira F. Mental deterioration, visuoperceptive disabilities and constructional apraxia in Parkinson's disease. Acta Neurologica Scandinavica 1982; 66: 112–120
   PubMed Web of Science ®Google Scholar
• Villardita C., Smimi P., Zappala G. Visual neglect in Parkinson's disease. Archives of Neurology 1983; 40: 737–739
   PubMed Web of Science ®Google Scholar
• Wilson S. A. K. Disorders of motility and muscle tone with special reference to the corpus striatum. Lancet 1925; 2: 1–10
   Google Scholar